Update on feline infectious peritonitis: Clinical trials
spotlight topic:
Clinical trials
Published 27 September 2023 | Updated 9 May 2025
- Kamiyoshi, T., Kamiyoshi, N., and Jintake, C. (2025) High-dose induction therapy and treatment termination criteria for feline infectious peritonitis with remdesivir, GS-441524 and adjunctive mefloquine: 46 cases (2023). Journal of Small Animal Practice. https://doi.org/10.1111/jsap.13869
- Clark, T.M. et al. (2025) Treatment of feline infectious peritonitis in cats with molnupiravir: clinical observations and outcomes for 54 cases. Australian Veterinary Journal. https://doi.org/10.1111/avj.13433
- Negash, R. et al. (2024) Owner experience and veterinary involvement with unlicensed GS-441524 treatment of feline infectious peritonitis: a prospective cohort study. Frontiers in Veterinary Science, 11. https://doi.org/10.3389/fvets.2024.1377207
- Coggins, S.J. et al. (2023) Outcomes of treatment of cats with feline infectious peritonitis using parenterally administered remdesivir, with or without transition to orally administered GS‐441524. Journal of Veterinary Internal Medicine, 37 (5), pp. 1772-1783. https://doi.org/10.1111/jvim.16803
- Cosaro, E. et al. (2023) Efficacy of oral remdesivir compared to GS-441524 for treatment of cats with naturally occurring effusive feline infectious peritonitis: A blinded, non-inferiority study. Viruses, 15 (8), no.1680. https://doi.org/10.3390/v15081680
Claiming CPD for reading inFOCUS articles
Reading and reflecting on articles can count towards your CPD, and we have a template to help you with the process.
Online full-text available to Library members
A range of library membership packages is available and MRCVS vets and RVNs can join the library for a heavily subsidised, annual fee.
Leave a Reply
Want to join the discussion?Feel free to contribute!